MedWatch

GN Hearing lets staff go to optimize supply chain

The hearing aid manufacturer plans to invest around DKK 150m (USD 21.4m) on streamlining its supply chain in 2022. So far, the first DKK 29m (USD 4.1m) has gone to employee dismissals, GN Hearing CEO Gitte Aabo tells MedWatch.

Gitte Aabo, CEO of GN Hearing | Photo: GN Hearing / PR

GN Hearing is optimizing its business and paying close attention to its supply chain with the aim of regaining profitability in challenging times, as freight and logistical issues, on top of the Covid-19 pandemic, continue to affect the hearing aid market.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs